title: First appearance of Crohn's disease following infliximab treatment for spondylarthropathy.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Tsochatzis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Vassilopoulos
authors.forename: Emanuel K
authors.initials: EK
authors.lastname: Manesis
authors.forename: George
authors.initials: G
authors.lastname: Papatheodoridis
authors.forename: Ageliki
authors.initials: A
authors.lastname: Bousiotou
authors.forename: Emilia
authors.initials: E
authors.lastname: Hadziyannis
authors.forename: Athanasios J
authors.initials: AJ
authors.lastname: Archimandritis
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000139:chemically induced*; D006801:Humans; D000069285:Infliximab; D008297:Male; D025242:Spondylarthropathies / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab